TRINITY BIOTECH (UK) LIMITED

Company Registration Number:
08606499 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2023

Period of accounts

Start date: 1 January 2023

End date: 31 December 2023

TRINITY BIOTECH (UK) LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2023

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

TRINITY BIOTECH (UK) LIMITED

Directors' report period ended 31 December 2023

The directors present their report with the financial statements of the company for the period ended 31 December 2023

Principal activities of the company

Trinity Biotech (UK) Limited (the “Company”) is part of the Trinity Biotech plc group (the “group”). The Company’s principal activity is to support other group companies. The Company does not carry out any manufacturing since the manufacturing facilities in the UK were closed in July 2014 and the operations were relocated to Bray, Ireland and Jamestown, New York.



Directors

The directors shown below have held office during the whole of the period from
1 January 2023 to 31 December 2023

Dr. Jim Walsh
John Gillard


Secretary John Gillard

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
9 October 2024

And signed on behalf of the board by:
Name: John Gillard
Status: Secretary

TRINITY BIOTECH (UK) LIMITED

Profit And Loss Account

for the Period Ended 31 December 2023

2023 2022


£

£
Turnover: 86,000 87,000
Gross profit(or loss): 86,000 87,000
Administrative expenses: ( 90,000 ) ( 83,000 )
Operating profit(or loss): (4,000) 4,000
Interest payable and similar charges: ( 94,000 ) ( 25,000 )
Profit(or loss) before tax: (98,000) (21,000)
Profit(or loss) for the financial year: (98,000) (21,000)

TRINITY BIOTECH (UK) LIMITED

Balance sheet

As at 31 December 2023

Notes 2023 2022


£

£
Current assets
Debtors: 3 180,000 747,000
Cash at bank and in hand: 2,000 5,000
Total current assets: 182,000 752,000
Creditors: amounts falling due within one year: 4 ( 243,000 ) ( 715,000 )
Net current assets (liabilities): (61,000) 37,000
Total assets less current liabilities: (61,000) 37,000
Total net assets (liabilities): (61,000) 37,000
Capital and reserves
Called up share capital: 1 1
Profit and loss account: (61,001 ) 36,999
Total Shareholders' funds: ( 61,000 ) 37,000

The notes form part of these financial statements

TRINITY BIOTECH (UK) LIMITED

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 9 October 2024
and signed on behalf of the board by:

Name: John Gillard
Status: Director

The notes form part of these financial statements

TRINITY BIOTECH (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

    Other accounting policies

    Going concern Foreign currency Intercompany Other payables Cash Share capital Financial instruments Employee benefits Tax Provisions Fair Values

TRINITY BIOTECH (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 1 1

TRINITY BIOTECH (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Debtors

2023 2022
£ £
Other debtors 180,000 747,000
Total 180,000 747,000

TRINITY BIOTECH (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Creditors: amounts falling due within one year note

2023 2022
£ £
Other creditors 243,000 715,000
Total 243,000 715,000